---
title: Virtual Reality and White Noise During Peripheral IV Catheterization in Adults
nct_id: NCT07241988
overall_status: COMPLETED
phase: NA
sponsor: Gizem Göktuna
study_type: INTERVENTIONAL
primary_condition: Peripheral Intravenous Catheterization
countries: Turkey (Türkiye)
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT07241988.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT07241988"
ct_last_update_post_date: 2026-03-24
last_seen_at: "2026-05-12T06:15:56.085Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Virtual Reality and White Noise During Peripheral IV Catheterization in Adults

**Official Title:** The Effect of Virtual Reality Glasses and White Noise on Pain, Anxiety, and Satisfaction During Peripheral Intravenous Catheterization in Adults: A Randomized Controlled Trial

**NCT ID:** [NCT07241988](https://clinicaltrials.gov/study/NCT07241988)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 76
- **Lead Sponsor:** Gizem Göktuna
- **Conditions:** Peripheral Intravenous Catheterization, Pain, Anxiety, Patient Satisfaction
- **Start Date:** 2025-10-11
- **Completion Date:** 2026-01-30
- **CT.gov Last Update:** 2026-03-24

## Brief Summary

This randomized controlled study aims to examine the effects of using virtual reality glasses and white noise during peripheral intravenous catheterization on pain, anxiety, and satisfaction in adult patients. Participants will be randomly assigned to one of three groups: virtual reality, white noise, or control. Pain and anxiety levels will be assessed using standardized scales immediately after the procedure, and satisfaction will be evaluated following the intervention. The study aims to determine whether these non-pharmacological methods can reduce pain and anxiety and increase patient satisfaction during intravenous catheterization.

## Eligibility

- **Minimum age:** 18 Years
- **Maximum age:** 85 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* No verbal, visual, auditory, or perceptual communication impairment
* Voluntary participation in the study
* Clinical requirement for peripheral intravenous catheterization
* No use of analgesic medication within the last 24 hours
* No diagnosed neurological or psychiatric disorder
* Ability to speak and understand Turkish
* Successful peripheral intravenous catheterization on the first attempt

Exclusion Criteria:

* Under 18 years of age
* Clinically unstable condition
* Individuals with psychiatric, mental, visual, or hearing impairments that prevent effective communication
* Individuals experiencing pain for any reason or using analgesic medication for pain management
* Individuals using anxiolytic or sedative medications
* Individuals who do not consent to participate in the study
```

## Arms

- **Virtual Reality Group** (EXPERIMENTAL) — Participants in this group will wear virtual reality glasses displaying relaxing nature scenes during peripheral intravenous catheterization. The intervention will begin three minute before the procedure and continue until catheter insertion is completed.
- **White Noise Group** (EXPERIMENTAL) — Participants in this group will listen to natural white noise (the sound of rain) through headphones during peripheral intravenous catheterization. The sound will begin three minutes before the procedure and continue until the catheterization is completed.
- **Control Group** (NO_INTERVENTION) — Participants in this group will receive routine peripheral intravenous catheterization without any additional intervention.

## Interventions

- **Virtual Reality Glasses** (BEHAVIORAL) — Participants in this group will wear virtual reality glasses displaying calming nature scenes accompanied by ambient sounds during peripheral intravenous catheterization. The intervention will begin three minutes before the procedure and continue until completion. This visual distraction technique is intended to reduce pain perception and anxiety levels and to increase patient satisfaction during the procedure.
- **White Noise (Rain Sound)** (BEHAVIORAL) — Participants will listen to natural white noise, specifically the sound of rain, through headphones during peripheral intravenous catheterization. The sound will begin three minutes before the procedure and continue until completion. This auditory distraction technique is intended to reduce pain perception and anxiety levels and to increase patient satisfaction during the procedure.

## Primary Outcomes

- **ain intensity during peripheral intravenous catheterization** _(time frame: Immediately after peripheral intravenous catheterization)_ — Pain intensity will be measured using a Visual Analogue Scale (VAS) ranging from 0 (no pain) to 10 (worst possible pain) immediately after the procedure.

## Secondary Outcomes

- **Anxiety level during peripheral intravenous catheterization** _(time frame: Three minutes before and immediately after the peripheral intravenous catheterization)_
- **Patient satisfaction related to peripheral intravenous catheterization** _(time frame: Three minutes before and immediately after the peripheral intravenous catheterization)_

## Locations (1)

- Dokuz Eylul University Hospital, İzmir, Balıkesir, Turkey (Türkiye)

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.dokuz eylul university hospital|i̇zmir|balıkesir|turkey (türkiye)` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT07241988.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT07241988*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*